FDA Approves IStent

Eye world

The U.S. Food and Drug Administration (FDA) has approved the iStent Trabecular Micro-Bypass (Glaukos Corp., Laguna Hills, Calif.), the first-ever ab interno implant for the treatment of glaucoma.